COX Inhibitors: Making the Best Choice for the Laminitic Case

Journal of Equine Veterinary Science

Volumn 28, Issue 6, 2008, Pages 367-369

  Divers, Thomas J ^a  

^a Animal Health Diagnostic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44649133991     PISSN: 07370806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jevs.2008.04.006     Document Type: Article

References (19)

1. st century. Subcell Biochem 42 (2007) 3-27
2. Burdan F., Chalas A., and Szumilo J. Cyclooxygenase and prostanoids: biological implications. Postepy Hig Med Dosw 60 (2006) 129-141
3. Doucet M.Y., Bertone A.L., Hendrickson D., Hughes F., Macallister C., McClure S., et al. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. J Am Vet Med Assoc 232 (2008) 91-97
4. Tomlinson J.E., and Blikslager A.T. Effects of cyclooxygenase inhibitors flunixin and deracoxib on permeability of ischaemic-injured equine jejunum. Equine Vet J 37 (2005) 75-80
5. Tomlinson J.E., Wilder B.O., Young K.M., and Blikslager A.T. Effects of flunixin meglumine or etodoiac treatment on mucosal recovery of equine jejunum after ischemia. Am J Vet Res 65 (2004) 761-769
6. Beretta C., Garavaglia G., and Cavalli M. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxican: an in vitro analysis. Pharmacol Res 52 (2005) 302-306
7. Sinclair M.D., Mealey K.L., Matthews N.S., Peck K.E., Taylor T.S., and Bennett B.S. Comparative pharmacokinetics of meloxican in clinically normal horses and donkeys. Am J Vet Res 67 (2006) 1082-1085
8. Little D., Brown S.A., Campbell N.B., Moeser A.J., Davis J.L., and Blikslager A.T. Effects of cyclooxygenase inhibitor meloxicam on recovery of ischemia-injured equine jejunum. Am J Vet Res 68 (2007) 614-624
9. Brideau C., Van Staden C., and Chan C.C. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. Am J Vet Res 62 (2001) 1755-1760
10. Owens J.G., Kamerling S.G., Stanton S.R., and Keowen M.L. Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. Equine Vet J 27 (1995) 296-300
11. Moore J.N., Hardee M.M., and Hardee G.E. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor. Am J Vet Res 47 (1996) 110-113
12. Semrad S.D., Hardee G.E., Hardee M.M., and Moore J.N. Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. Equine Vet J 19 (1987) 201-206
13. Reed S.K., Messer N.T., Tessman R.K., and Keegan K.G. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Am J Vet Res 67 (2006) 398-402
14. Peek S.F., Semrad S.D., and Perkins G.A. Clostridial myonecrosis in horses (37 cases 1985-2000). Equine Vet J 35 (2003) 86-92
15. Cambridge H., Lees P., Hooke R.E., and Russell C.S. Antithrombotic actions of aspirin in the horse. Equine Vet J 23 (1991) 123-127
16. Jarvis G.E., and Evans R.J. Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro. Blood Coag Fibrinolysis 7 (1996) 194-198
17. Mealey K.L., Matthews N.S., Peck K.E., Ray A.C., and Taylor T.S. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys. Am J Vet Res 58 (1997) 53-55
18. Coakley M., Peck K.E., Taylor T.S., Matthews N.S., and Mealey K.L. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses. Am J Vet Res 60 (1999) 1441-1444
19. Snow D.H., Douglas T.A., Thompson H., Parkins J.J., and Holmes P.H. Phenylbutazone toxicosis in equidae: a biochemical and pathophysiological study. Am J Vet Res 42 (1981) 1754-1759